Portfolio (Quarterly)
Guide ↗
Trails Edge Capital Partners, LP
· CIK 0002077247| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | 1,738,110.0 | $32.9M | 7.53% | NEW | — | $18.90 | +8.4% |
| 2 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 245,000.0 | $23.8M | 5.46% | NEW | — | $97.25 | +48.5% |
| 3 | CYTK | CYTOKINETICS INC | Healthcare | 300,000.0 | $19.8M | 4.53% | NEW | — | $65.91 | +14.1% |
| 4 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 701,821.0 | $16.4M | 3.76% | NEW | — | $23.36 | -16.9% |
| 5 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 1,302,917.0 | $12.1M | 2.78% | NEW | — | $9.31 | -10.1% |
| 6 | XENE PUT | XENON PHARMACEUTICALS INC | Healthcare | 200,000.0 | $11.6M | 2.66% | NEW | — | $58.15 | -7.6% |
| 7 | DSGN | DESIGN THERAPEUTICS INC | Healthcare | 852,013.0 | $9.1M | 2.08% | NEW | — | $10.64 | +0.6% |
| 8 | NERV | MINERVA NEUROSCIENCES INC | Healthcare | 1,419,000.0 | $8.5M | 1.96% | NEW | — | $6.03 | -27.6% |
| 9 | — | PROMIS NEUROSCIENCES INC | — | 557,103.0 | $7.1M | 1.62% | NEW | — | $12.70 | — |
| 10 | SLGL | SOL-GEL TECHNOLOGIES LTD | Healthcare | 85,496.0 | $6.8M | 1.55% | NEW | — | $79.22 | -20.1% |
| 11 | IPSC | CENTURY THERAPEUTICS INC | Healthcare | 2,449,993.0 | $5.5M | 1.27% | NEW | — | $2.26 | -6.2% |
| 12 | SNSE | SENSEI BIOTHERAPEUTICS INC | Healthcare | 125,000.0 | $3.9M | 0.90% | NEW | — | $31.52 | -46.8% |
| 13 | — | OPUS GENETICS INC | — | 500,000.0 | $2.3M | 0.52% | NEW | — | $4.55 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%